Do Exame Dermatológico ao Diagnóstico Sistémico: Síndrome de Sézary
DOI:
https://doi.org/10.24950/rspmi.2730Palavras-chave:
Dermatite Esfoliativa, Linfoma Cutânea de Células T/diagnóstico, Síndrome de Sézary/diagnósticoDownloads
Referências
1. Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94:1027-41. doi: 10.1002/ajh.25577.
2. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064-73. doi: 10.1182/blood-2008-10-184168.
3. Thompson AK, Killian JM, Weaver AL, Pittelkow MR, Davis MD. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic. J Am Acad Dermatol. 2017;76:683-8. doi: 10.1016/j.jaad.2016.10.029.
4. Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol. 2015;173:93-105. doi: 10.1111/bjd.13832.
Downloads
Publicado
Como Citar
Edição
Secção
Categorias
Licença
Direitos de Autor (c) 2026 Revista Portuguesa de Medicina Interna
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
